Figure 6.
Determining the antiviral efficacy of free HMW poly(I:C) and Nano-HMW against VHSV-IVa. RTgutGC cells grown in a monolayer were infected with viral hemorrhagic septicemia virus strain IVa (VHSV-Iva; MOI = 1) 6 hr after treatment with HMW poly(I:C) or Nano-HMW at 1000 ng/mL. Controls included cells treated with media alone (CTRL), cells treated with media and infected by virus (CTRL infect), cells treated with NP alone (Nano-mock) and not infected (Nano) and infected (Nano infect). Cell viability was measured by Alamar Blue assay (A). Resulting virus titers from the cell supernatant were measured by TCID50 assay (B). Data are presented as mean ± SEM. Three independent trials were conducted. Data were analyzed by a one-way ANOVA with a Dunnett’s test. (p < 0.05). Different letters show significant differences between groups.
